Welcome to LookChem.com Sign In|Join Free
  • or
2(5H)-Furanone, 5-hydroxy-5-methyl-4-[4-(methylsulfonyl)phenyl]-3-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

185147-19-7

Post Buying Request

185147-19-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

185147-19-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185147-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,1,4 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 185147-19:
(8*1)+(7*8)+(6*5)+(5*1)+(4*4)+(3*7)+(2*1)+(1*9)=147
147 % 10 = 7
So 185147-19-7 is a valid CAS Registry Number.

185147-19-7Relevant academic research and scientific papers

3,4-Diaryl-5-hydroxyfuranones: Highly selective inhibitors of cyclooxygenase-2 with aqueous solubility

Black, W. Cameron,Brideau, Christine,Chan, Chi-Chung,Charleson, Stella,Cromlish, Wanda,Gordon, Robert,Grimm, Erich L.,Hughes, Gregory,Leger, Serge,Li, Chun-Sing,Riendeau, Denis,Therien, Michel,Wang, Zhaoyin,Xu, Li-Jing,Prasit, Petpiboon

, p. 1195 - 1198 (2007/10/03)

The introduction of a hydroxyl group into the 5-position of the diaryl furanone system provides highly selective inhibitors of cyclooxygenase-2. These molecules can be converted into their sodium salts which are water soluble, facilitating intravenous formulation. These salts show excellent potency in rat models of pain, fever and inflammation.

Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 185147-19-7